Cardiol Therapeut…
USUSDCardiol Therapeutics Inc Class A (US:CRDL) — Biotechnology: Biological Products (No Diagnostic Substances). Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 2. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.
Apie Įmonę
- Svetainė
- cardiolrx.com
- Investuotojams
- cardiolrx.com/investors/events-presentations/
- Sektorius
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Būstinė
- OAKVILLE, Canada
- Generalinis Direktorius
- David G. Elsley
- Darbuotojai
- 18
- Apyvartoje Esančios Akcijos
- 121.51 mln. 2025-12-31 duomenimis
- Laisvai Apyvartinės Akcijos
- 91.98 mln.
- Rinkos Kapitalizacija
- 149.46 mln. USD
- Insaideriai
- 2.27%
- Instituciniai Investuotojai
- 26.4%
- Šaka (SIC)
- Biological Products, (No Diagnostic Substances)
- P/E
- nuostolis
- FCF
- −23.9 mln. CAD
- Skola
- ?
- Pelnas ir FCF – už 12 mėnesių iki 31.12.2025 (naujausia įmonės ataskaita).
Aprašymas
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Didžiausi Akcininkai
| Turėtojas | Dalis | Akcijos | Ataskaitos Data |
|---|---|---|---|
| MMCAP International, Inc… | 13.12% | 15.6 mln. | 2026-06-30 |
| Tejara Capital Ltd | 4.3% | 5.11 mln. | 2026-06-30 |
| Ikarian Capital, LLC | 2.8% | 3.33 mln. | 2026-06-30 |
| Elsley (David) (Director… | ≈1.13% | 1.34 mln. | 2025-10-17 |
| Boothbay Fund Management… | 0.82% | 975 721 | 2026-06-30 |
| Citadel Advisors Llc | 0.67% | 796 529 | 2026-06-30 |
| Renaissance Technologies… | 0.65% | 772 837 | 2026-06-30 |
| Two Sigma Investments, L… | 0.63% | 746 937 | 2026-06-30 |
| Hamer (Andrew Warwick M.… | ≈0.62% | 739 947 | 2026-08-28 |
| Integrity Alliance, Llc. | 0.33% | 388 492 | 2026-06-30 |
| Morgan Stanley | 0.3% | 355 030 | 2026-06-30 |
| Torreamione (Guilermo) (… | ≈0.28% | 334 309 | 2026-09-08 |
| Goldman Sachs Group Inc | 0.28% | 333 900 | 2026-06-30 |
| Chao (Jennifer M) (Direc… | ≈0.12% | 146 667 | 2026-08-21 |
| Loxam (Teri) (Director o… | ≈0.12% | 146 667 | 2026-08-21 |
| Fidelity Concord Street… | 0.05% | 60 663 | 2026-07-31 |
